A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Public ClinicalTrials.gov record NCT06038578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Open-Label, Phase 2 Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Study identification
- NCT ID
- NCT06038578
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Toray Industries, Inc
- Industry
- Enrollment
- 146 participants
Conditions and interventions
Interventions
- TRK-950 Biological
- Ramucirumab Drug
- Paclitaxel Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 3, 2023
- Primary completion
- Jun 29, 2026
- Completion
- Jun 29, 2026
- Last update posted
- Jun 22, 2026
2023 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 2
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | Recruiting |
| City of Hope at Orange County Lennar Foundation Cancer Center | Irvine | California | 92618 | Recruiting |
| University of California, Los Angeles | Santa Monica | California | 90404 | Recruiting |
| Texas Oncology Arlington North | Arlington | Texas | 76012 | Recruiting |
| Texas Oncology Bedford | Bedford | Texas | 76022 | Recruiting |
| Texas Oncology Dallas Methodist | Dallas | Texas | 75203 | Recruiting |
| Texas Oncology Dallas Medical City | Dallas | Texas | 75230 | Recruiting |
| Texas Oncology Dallas Presbyterian | Dallas | Texas | 75231 | Recruiting |
| Texas Oncology Methodist Charlton Cancer Center | Dallas | Texas | 75237 | Recruiting |
| Texas Oncology-Sammons Cancer Center | Dallas | Texas | 75246 | Recruiting |
| Texas Oncology Fort Worth Cancer Center | Fort Worth | Texas | 76104 | Recruiting |
| Texas Oncology Grapevine | Grapevine | Texas | 76051 | Recruiting |
| Texas Oncology Plano East | Plano | Texas | 75075 | Recruiting |
| Texas Oncology Plano West | Plano | Texas | 75093 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06038578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06038578 live on ClinicalTrials.gov.